ETASTs in the peripheral blood of patients with NSCLC were activated by TATAN, followed by detecting activation markers IFN‐γ and CD137 for the quantitative analysis of ETASTs. The gene discussed is TNFRSF9; the disease is non-small cell lung carcinoma.